This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cramer's 'Mad Money' Recap: Balancing Act (Final)

Private Label Boom

In yet another "Executive Decision" segment, Cramer once again sat down with Joe Papa, chairman, president and CEO of private label drugmaker Perrigo (PRGO), a long-time Cramer favorite.

Papa said that while the economy is improving, and migration to private label brands is slowing, he's focused on the fact that 91% of consumers who try a private label brand stick with it in the future. Even more exciting are the 45 new products that Perrigo will be introducing this year which represent a $190 million opportunity for the company.

Papa was also upbeat about Perrigo's longer-term pipeline, as over $10 billion worth of prescription drugs will be moving over-the-counter over the next five years. Some of the notable brands Perrigo is targeting include Mucinex, Prevacid, Delsym, Claritin-D and Allegra-D.

When asked about the warmer weather and lower birth rates here in the U.S., Papa said that Perrigo's cough, cold and flue segment is down about 8% this season but since that group only accounts for 12% of sales, he's not worried. Likewise with the 3% drop in birth rates this year. Papa said the stronger trend is that of new parents ditching the national brands for Perrigo's private label alternatives.

Papa's final point of interest was the fact that Perrigo manufactures many of its own active ingredients, which often account for 40% to 50% of the overall cost of the product. Because this process is in-house, Papa said Perrigo is not seeing as much commodity price pressure as some other companies do.

Cramer continues his support for Perrigo.

Lightning Round

Cramer was bullish on Harman International (HAR - Get Report), Covidien (COV), Life Technologies (LIFE), People's Bank (PBCT - Get Report), Goldman Sachs (GS - Get Report), Morgan Stanley (MS - Get Report), Pfizer (PFE - Get Report), Bristol-Myers Squibb (BMY), Ford Motor (F) and Alcoa (AA).

Cramer was bearish on Dendreon (DNDN), VOXX International (VOXX), Pepsico (PEP), Walgreens (WAG) and Linn Energy (LINE).

Special ETF

In a quick "All Request Week" segment, Cramer explained why he recommends the SPDR Gold Shares (GLD) ETFs and not any other exchange traded funds.

He said unlike other ETFs, the "GLD" is not a basket of stocks but rather a fund that tracks the actual price of the commodity. When it comes to baskets of stocks, Cramer said "you can do better" by picking only the best stocks in certain sectors.

So why buy the GLD and not actual gold? Cramer said it's because buying gold is hard, as it requires storage. He said he's a fan of coins, but the markup in coins is often outrageous. And when it comes to gold mining stocks, these companies face many challenges and cannot be relied on.

That's why Cramer said he's always been a fan of the GLD and its cousin, the iShares Gold Trust (IAU), a fun which he owns for his charitable trust, Action Alerts PLUS .

--Written by Scott Rutt in Washington, D.C.

To contact the writer of this article, click here: Scott Rutt.

Follow TheStreet on Twitter and become a fan on Facebook.

To submit a news tip, send an email to:

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

Want more Cramer? Check out Jim's rules and commandments for investing from his latest book by clicking here.

For more of Cramer's insights during the Lightning Round, click here .
At the time of publication, Cramer was long iShares Gold Trust.

Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for, Inc., and CNBC, and a director and co-founder of All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of or its affiliates, or CNBC, NBC UNIVERSAL or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or is related to the specific opinions expressed by him on "Mad Money."

None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BWLD $136.90 2.40%
COV $106.71 -1.26%
HAR $76.58 -0.23%
GS $166.22 1.30%
LIFE $3.65 -95.00%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs